MAPK3 and chronic myelogenous leukemia, BCR-ABL1 positive: Tamoxifen treatment effectively reduced PRMT1 expression in leukemia cells from Prmt1fl/fl; Cre‐ERT2 CML mice (Figure S4B, Supporting Information).